Verastem (VSTM)
(Delayed Data from NSDQ)
$2.50 USD
+0.04 (1.63%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $2.48 -0.02 (-0.80%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For VSTM
-
Verastem: Q2 Earnings Snapshot
-
Verastem Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Updates
-
Verastem: Q1 Earnings Snapshot
-
Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
-
Verastem: Q4 Earnings Snapshot
-
Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates
-
Verastem: Q3 Earnings Snapshot
-
Verastem Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
-
Verastem: Q2 Earnings Snapshot
-
Verastem Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
-
Verastem: Q1 Earnings Snapshot
-
Verastem Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
-
Verastem: Q4 Earnings Snapshot
-
Verastem Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
-
Verastem: Q3 Earnings Snapshot
-
Verastem Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
-
Verastem: Q2 Earnings Snapshot
-
Verastem Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
-
Verastem (VSTM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Earnings Estimates Moving Higher for Verastem (VSTM): Time to Buy?
-
Verastem (VSTM) Reports Q3 Loss, Misses Revenue Estimates
-
Verastem (VSTM) Reports Q2 Loss, Tops Revenue Estimates
-
Verastem (VSTM) Reports Q1 Loss, Lags Revenue Estimates
-
Verastem (VSTM) Reports Q4 Loss, Misses Revenue Estimates
-
What's in Store for Verastem (VSTM) This Earnings Season?